ETF Managers Group LLC purchased a new position in shares of Sanofi (NASDAQ:SNY – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 2,898 shares of the company’s stock, valued at approximately $158,000.
Several other institutional investors and hedge funds have also modified their holdings of the business. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Sanofi by 10.4% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 2,221 shares of the company’s stock worth $108,000 after acquiring an additional 210 shares during the last quarter. China Universal Asset Management Co. Ltd. raised its position in shares of Sanofi by 7.7% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,935 shares of the company’s stock valued at $142,000 after purchasing an additional 211 shares during the period. Good Life Advisors LLC raised its position in shares of Sanofi by 3.7% during the 4th quarter. Good Life Advisors LLC now owns 5,858 shares of the company’s stock valued at $284,000 after purchasing an additional 211 shares during the period. Archer Investment Corp raised its position in shares of Sanofi by 6.4% during the 4th quarter. Archer Investment Corp now owns 3,990 shares of the company’s stock valued at $193,000 after purchasing an additional 240 shares during the period. Finally, Allworth Financial LP raised its position in shares of Sanofi by 17.5% during the 4th quarter. Allworth Financial LP now owns 1,638 shares of the company’s stock valued at $79,000 after purchasing an additional 244 shares during the period. Hedge funds and other institutional investors own 10.67% of the company’s stock.
Sanofi Stock Performance
Sanofi stock opened at $53.90 on Friday. The company’s 50-day moving average price is $53.15 and its 200-day moving average price is $52.04. Sanofi has a twelve month low of $36.91 and a twelve month high of $57.82. The company has a quick ratio of 1.05, a current ratio of 1.42 and a debt-to-equity ratio of 0.20. The company has a market cap of $135.94 billion, a PE ratio of 19.32, a price-to-earnings-growth ratio of 1.73 and a beta of 0.57.
Sanofi Cuts Dividend
The company also recently declared an annual dividend, which was paid on Friday, June 23rd. Investors of record on Wednesday, May 31st were paid a dividend of $1.377 per share. The ex-dividend date of this dividend was Tuesday, May 30th. This represents a dividend yield of 2.94%. Sanofi’s dividend payout ratio is presently 49.46%.
Analyst Upgrades and Downgrades
SNY has been the topic of several recent analyst reports. Barclays upgraded shares of Sanofi from an “equal weight” rating to an “overweight” rating in a research report on Monday, March 27th. Argus raised their price objective on shares of Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Monday, March 27th. StockNews.com downgraded shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 13th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Sanofi from a “hold” rating to a “sell” rating in a report on Friday, April 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.00.
Sanofi Profile
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.
Recommended Stories
- Five stocks we like better than Sanofi
- MarketBeat Week in Review – 6/26 – 6/30
- Tesla: Can Downgrades Make Sense After A 170% Rally?
- Buffett’s Berkshire Increases Stake In Occidental Petroleum (OXY)
- Rally Gains Momentum On Soft PCE Data
- Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
